For instance, the Lynch syndrome genes MLH1, MSH2, MSH6, PMS2, and EPCAM are included in the guidelines to be managed based on family history [18] and are commonly screened during breast cancer genetic risk assessment [23, 24], but were not included in this analysis. This evidence concerns the gene EPCAM and breast cancer.